Stock SPRO SPERO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Spero Therapeutics, Inc.

Equities

SPRO

US84833T1034

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-03 pm EDT 		5-day change 1st Jan Change
1.63 USD +1.24% Intraday chart for Spero Therapeutics, Inc. +11.64% +10.88%
Mar. 13 Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Mar. 13 Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SPERO THERAPEUTICS, INC. Stock Spero Therapeutics, Inc.
 87.85M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 104B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.34B -
GENMAB A/S Stock Genmab A/S
 19.25B
  1. Stock Market
  2. Equities
  3. SPRO Stock
  4. Charts Spero Therapeutics, Inc.
  5. Sector Chart